Effects of Medicare comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications among patients with Alzheimer’s Disease: an observational analysis

Table 3 Effects of comprehensive medication review on racial/ethnic disparities in nonadherence to statin medications

	Coefficient Estimate	Standard Error	Odds Ratio	95% Confidence Interval	P value
Predisposing Factors
Race/Ethnicity
Blacks	0.22	0.02	1.25	1.21–1.29	< 0.0001
Hispanics	0.26	0.03	1.29	1.23–1.36	< 0.0001
Asians/Pacific Islanders	0.03	0.07	1.03	0.91–1.18	0.63
Others	0.10	0.05	1.11	1.01–1.22	0.03
CMR receipt	−0.49	0.01	0.61	0.60–0.63	< 0.0001
CMR × Blacks	0.01	0.02	1.01	0.97–1.06	0.58
CMR × Hispanics	−0.11	0.03	0.89	0.85–0.94	< 0.0001
CMR × Asians/Pacific Islanders	−0.06	0.05	0.94	0.85–1.05	0.27
CMR × Others	−0.11	0.07	0.89	0.77–1.03	0.12
Age	−0.002	0.0006	1.00	1.00–1.00	0.0001
Male	−0.11	0.01	0.89	0.88–0.91	< 0.0001
Proportion of Married-Couple Families^a	−0.37	0.10	0.69	0.57–0.83	< 0.0001
Proportion of Education ≥ High School^a	0.25	0.20	1.28	0.87–1.90	0.21
Per Capita Income (in $1000)^a	< 0.0001	0.0004	1.00	1.00–1.00	0.93
Proportion of No Insurance^a	1.13	0.15	3.11	2.33–4.15	< 0.0001
Year 2016	−0.06	0.01	0.94	0.93–0.96	< 0.0001
Year 2017	−0.23	0.01	0.80	0.78–0.81	< 0.0001
Enabling Factors
Metropolitan Statistical Area^a	0.04	0.01	1.04	1.01–1.07	0.01
Health Professional Shortage Area^a	0.01	0.02	1.01	0.98–1.04	0.55
Census Regions^a
Midwest	0.02	0.02	1.02	0.98–1.07	0.38
South	0.14	0.02	1.15	1.11–1.19	< 0.0001
West	0.01	0.04	1.01	0.94–1.09	0.81
Need Factor
Risk Adjustment Summary Score	0.19	0.004	1.21	1.20–1.21	< 0.0001

Reference groups for categorical variables: Non-Hispanic Whites, CMR non-recipients, female, year 2015, non-Metropolitan Statistical Area, non-Health Professional Shortage Area, and Northeast region
Abbreviation: CMR Comprehensive Medication Review
^aCommunity-level factors

ISSN: 1472-6963